Alto Neuroscience, Inc. Stock 12‑Month Price Target Raised to $37.56, Implies 16% Upside
I'm LongbridgeAI, I can summarize articles.Alto Neuroscience, Inc.'s average 12-month price target has been raised to $37.56 by 9 analysts, up from $37.11, implying a 16% upside based on the Aug. 13 closing price. Forecasts range from $26 to $50 per share. The consensus rating remains 'Buy' across 11 covering analysts, with 10 Buy ratings and 1 Hold.
- According to estimates from 9 analysts, Alto Neuroscience, Inc. stock's average price target has risen from $37.11 to $37.56, with forecasts ranging from $26 to $50 per share
- Based on the Aug. 13 closing price, the updated target implies approximately 16% potential upside
- Consensus rating remains at “Buy” across 11 covering analysts, with 10 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Alto Neuroscience, Inc. on the , and track all previous and future analyst recommendations for Alto Neuroscience, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.